TD Cowen Initiates Coverage on LENZ Therapeutics (NASDAQ:LENZ)

Equities research analysts at TD Cowen began coverage on shares of LENZ Therapeutics (NASDAQ:LENZ – Get Free Report) in a research note issued on Tuesday, MarketBeat.com reports. The firm set a “buy” rating and a $60.00 price target on the stock. TD Cowen’s price target would suggest a potential upside of 135.11% from the company’s […]

Mar 20, 2025 - 07:51
 0
TD Cowen Initiates Coverage on LENZ Therapeutics (NASDAQ:LENZ)
Equities research analysts at TD Cowen began coverage on shares of LENZ Therapeutics (NASDAQ:LENZ – Get Free Report) in a research note issued on Tuesday, MarketBeat.com reports. The firm set a “buy” rating and a $60.00 price target on the stock. TD Cowen’s price target would suggest a potential upside of 135.11% from the company’s […]